FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1546822559> ?p ?o ?g. }

• W1546822559 endingPage "64" @default.
• W1546822559 startingPage "60" @default.
• W1546822559 abstract "Background We assessed the safety and efficacy of ifosfamide and vinorelbine (IV) as a less toxic and effective reinduction regimen for pediatric patients with relapsed or refractory Hodgkin Lymphoma. Procedure This multi‐center Children's Oncology Group phase II pilot study enrolled patients <30 years of age with biopsy‐proven Hodgkin Lymphoma in relapse or refractory disease after front‐line therapy. Treatment consisted of ifosfamide 3,000 mg/m 2 intravenous infusion over 24 hr on Days 1–4 and vinorelbine 25 mg/m 2 /dose intravenous push on Days 1 and 5 of each 21 day cycle with cytokine support. The study endpoints included estimation of key toxicities (cardiac, hepatic, or renal toxicity or toxic death), the rate of successful peripheral stem cell harvesting, and response after two cycles of therapy. Results Sixty‐six patients received a median of two cycles of IV. Sixty‐four of 66 were heavily pretreated, 4 had refractory disease, 55% were male and 79% had nodular sclerosis HL. The primary toxicities were hematologic. Harvested peripheral stem cells were sufficient for autologous transplantation in 46 of 54 patients for whom stem cell collection was attempted. The overall response rate (72%; 95% CI 59–83%) permitted the majority of patients to undergo subsequent stem cell transplantation. Conclusions IV is a safe and effective re‐induction regimen for salvage of pediatric patients with relapsed or refractory Hodgkin Lymphoma with an excellent response rate and success of post chemotherapy stem cell harvest. It avoids the use of etoposide, an agent associated with secondary malignancy after stem cell transplantation. Pediatr Blood Cancer 2015;62:60–64. © 2014 Wiley Periodicals, Inc." @default.
• W1546822559 created "2016-06-24" @default.
• W1546822559 creator A5000390660 @default.
• W1546822559 creator A5003639088 @default.
• W1546822559 creator A5025395169 @default.
• W1546822559 creator A5027056352 @default.
• W1546822559 creator A5037614274 @default.
• W1546822559 creator A5040001760 @default.
• W1546822559 creator A5046443666 @default.
• W1546822559 creator A5071074966 @default.
• W1546822559 creator A5073322914 @default.
• W1546822559 date "2014-10-12" @default.
• W1546822559 modified "2023-10-16" @default.
• W1546822559 title "Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: A children's oncology group report" @default.
• W1546822559 cites W1497143314 @default.
• W1546822559 cites W1856398768 @default.
• W1546822559 cites W1892398095 @default.
• W1546822559 cites W1936478602 @default.
• W1546822559 cites W1950269930 @default.
• W1546822559 cites W1998567244 @default.
• W1546822559 cites W2004871530 @default.
• W1546822559 cites W2034218339 @default.
• W1546822559 cites W2034481315 @default.
• W1546822559 cites W2037340212 @default.
• W1546822559 cites W2038252730 @default.
• W1546822559 cites W2049882831 @default.
• W1546822559 cites W2065408685 @default.
• W1546822559 cites W2093482493 @default.
• W1546822559 cites W2093787801 @default.
• W1546822559 cites W2115919161 @default.
• W1546822559 cites W2122654415 @default.
• W1546822559 cites W2139248078 @default.
• W1546822559 cites W2141082026 @default.
• W1546822559 cites W2147488444 @default.
• W1546822559 cites W2243629813 @default.
• W1546822559 cites W2254324119 @default.
• W1546822559 cites W2279918239 @default.
• W1546822559 cites W2288042566 @default.
• W1546822559 doi "https://doi.org/10.1002/pbc.25205" @default.
• W1546822559 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4465390" @default.
• W1546822559 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25308760" @default.
• W1546822559 hasPublicationYear "2014" @default.
• W1546822559 type Work @default.
• W1546822559 sameAs 1546822559 @default.
• W1546822559 citedByCount "20" @default.
• W1546822559 countsByYear W15468225592015 @default.
• W1546822559 countsByYear W15468225592016 @default.
• W1546822559 countsByYear W15468225592018 @default.
• W1546822559 countsByYear W15468225592019 @default.
• W1546822559 countsByYear W15468225592020 @default.
• W1546822559 countsByYear W15468225592021 @default.
• W1546822559 countsByYear W15468225592022 @default.
• W1546822559 countsByYear W15468225592023 @default.
• W1546822559 crossrefType "journal-article" @default.
• W1546822559 hasAuthorship W1546822559A5000390660 @default.
• W1546822559 hasAuthorship W1546822559A5003639088 @default.
• W1546822559 hasAuthorship W1546822559A5025395169 @default.
• W1546822559 hasAuthorship W1546822559A5027056352 @default.
• W1546822559 hasAuthorship W1546822559A5037614274 @default.
• W1546822559 hasAuthorship W1546822559A5040001760 @default.
• W1546822559 hasAuthorship W1546822559A5046443666 @default.
• W1546822559 hasAuthorship W1546822559A5071074966 @default.
• W1546822559 hasAuthorship W1546822559A5073322914 @default.
• W1546822559 hasBestOaLocation W15468225592 @default.
• W1546822559 hasConcept C126322002 @default.
• W1546822559 hasConcept C141071460 @default.
• W1546822559 hasConcept C143998085 @default.
• W1546822559 hasConcept C2776694085 @default.
• W1546822559 hasConcept C2777506904 @default.
• W1546822559 hasConcept C2778119113 @default.
• W1546822559 hasConcept C2778239845 @default.
• W1546822559 hasConcept C2779050716 @default.
• W1546822559 hasConcept C2780350996 @default.
• W1546822559 hasConcept C2780775027 @default.
• W1546822559 hasConcept C2781413609 @default.
• W1546822559 hasConcept C2911091166 @default.
• W1546822559 hasConcept C71924100 @default.
• W1546822559 hasConcept C90924648 @default.
• W1546822559 hasConceptScore W1546822559C126322002 @default.
• W1546822559 hasConceptScore W1546822559C141071460 @default.
• W1546822559 hasConceptScore W1546822559C143998085 @default.
• W1546822559 hasConceptScore W1546822559C2776694085 @default.
• W1546822559 hasConceptScore W1546822559C2777506904 @default.
• W1546822559 hasConceptScore W1546822559C2778119113 @default.
• W1546822559 hasConceptScore W1546822559C2778239845 @default.
• W1546822559 hasConceptScore W1546822559C2779050716 @default.
• W1546822559 hasConceptScore W1546822559C2780350996 @default.
• W1546822559 hasConceptScore W1546822559C2780775027 @default.
• W1546822559 hasConceptScore W1546822559C2781413609 @default.
• W1546822559 hasConceptScore W1546822559C2911091166 @default.
• W1546822559 hasConceptScore W1546822559C71924100 @default.
• W1546822559 hasConceptScore W1546822559C90924648 @default.
• W1546822559 hasIssue "1" @default.
• W1546822559 hasLocation W15468225591 @default.
• W1546822559 hasLocation W15468225592 @default.
• W1546822559 hasLocation W15468225593 @default.
• W1546822559 hasLocation W15468225594 @default.
• W1546822559 hasOpenAccess W1546822559 @default.

• next